KCSO | Brothers charged in drug-related death, one missing


February 11, 2013 · Updated 12:33 PM 

One of two brothers, charged in a drug-related death of a woman, is still at-large, according to Kitsap County Sheriff’s Office.

Matthew Peter Zapatka, 39, of Port Orchard, was charged with controlled substances homicide in the death of 49-year-old Shelly Ione Dubois, according to court documents filed Feb. 1 in Kitsap County Superior Court.

Zapatka’s brother, Stephen Anthony Zapatka, 46, also was charged with possession of a controlled substance with intent to deliver, court documents stated.Stephen Zapatka was arrested and jailed Feb. 4 on $150,000 bail.

Documents state on Nov. 23, KCSO deputies were called to a home on View Park Road for a reported overdose.When they arrived, they found Dubois, who was later pronounced dead at the scene.Investigators learned Zapatka had used heroin with Dubois that day.

They discovered she used a syringe full of heroin. Matthew Zapatka said when he found Dubois unresponsive, he used a drug that can reverse a heroin overdose. She didn’t respond to the drug given her, documents stated.

Documents reported cellphones found at the house where the death occurred and investigators found text messages that indicated the brothers provided heroin to Dubois.

Stephen Zapatka was the deceased woman's boyfriend.

Comment on this story.

COMMENTING RULES: We encourage an open exchange of ideas in our online community, but we ask you to follow our guidelines for respecting community standards. In a nutshell, don't say anything you wouldn't want your mother to read. Please see our FAQ if you have questions or concerns about using Facebook to comment.

So keep your comments:

  • Civil
  • Smart
  • On-topic
  • Free of profanity

We ask that all participants own their words by logging in with their Facebook account. It's a simple process that will take seconds and helps keep our comments free of trolls, cranks, and “drive-by” commenters. We reserve the right to remove comments from anyone using screen names, pseudonyms or false identities. Please refer to our Terms of Use for full detail on participating on our site.